维普中文期刊产品整合服务
60篇 您的检索式:作者名="Schwartsmann"
    题名 作者 年代 出处 被引量
1A phase I trial of the bombesin/gastrin-releasing peptide (BN/GRP) antagonist RC3095 in patients with advanced solid malignancies显示文摘G. Schwartsmann L. P. DiLeone M. Horowitz D. Schunemann A. Cancella A. S. Pereira M. Richter F. Souza A. Brondani Rocha F. H. Souza P. Pohlmann G. Nucci 2006Investigational New Drugs2006,,5:2
2Anticancer drug discovery and development throughout the world 显示文摘Schwartsmann G Ratain M J Cragg GM 2002J Clin Oncol2002,20,:1
3Glioma Revisited: From Neurogenesis and Cancer Stem Cells to the Epigenetic Regulation of the Niche显示文摘Felipe de Almeida Sassi Algemir Lunardi Brunetto Gilberto Schwartsmann Rafael Roesler Ana Lucia Abujamra Fabian Benencia 2012<journal-title>Journal of Oncology2012,,:1
4Anticancer, antichemotactic and antimicrobial activities of marine sponges collected off the coast of Santa Catarina, southern Brazil显示文摘Noel R Monks Clea Lerner Amélia T Henriques Fabiane M Farias Elfrides E.S Schapoval Edna S Suyenaga Adriana B da Rocha Gilberto Schwartsmann Beatriz Mothes 2002Journal of Experimental Marine Biology and Ecology2002,,1:1
5Marine-derived anticancer agents in clinical trials显示文摘Schwartsmann G Da Rocha AB Mattei J 2003Expert Opin Investig Drugs2003,12,8:1
6Marine organisms as a source of new anticancer agents 显示文摘Schwartsmann G Rocha AB Berlinck RGS 2001The Lancet Oncology2001,2,4:1
7In vivo inhibi-tion of the pyrimidine de novo enzyme dihydroorotic acid de-hydrogenase by brequinar sodium(DUP-785;NSC 368390) in mice and patients显示文摘Peters G J Schwartsmann G Nadal J C 0,,15:1
8Marine-derived anticancer agents in clinical trials 显示文摘Schwartsmann G Da Rocha AB Mattei J 2003Expert Opin Investig Drugs2003,12,8:1
9Sentinel lymph node in carcinoma of the anal canal显示文摘Damin DC Rosito MA Schwartsmann G 2006Eur J Surg Oncol2006,32,3:1
10Marine organisms as a source of new anticancer agents 显示文摘Schwartsmann G Brondani da Rocha A Berlinck RG 2001Lancet Oncol2001,2,:1
11A phaseⅠtrial of cisplatin plus decitabine,a new DNAhypomethylating agent,in patients with advanced solid tumors and a follow-up early phaseⅡevaluation in patients with inoperable non-small cell lung cancer显示文摘Schwartsmann G Schunemann H Gorini CN 2000Invest New Drug2000,18,1:1
12Expression of MMP- 9 and VEGF in breast cancer: correlation with other prognostic indicators显示文摘Jobim F C Schwartsmann G Xavier N L 2008Rev Bras Ginecol Obstet2008,30,6:1
13Expression of MMP-9 and VEGF in breast cancer:correlation with other prognostic indicators显示文摘Jobim FC Schwartsmann G Xavier NL 2008Rev Bras Ginecol Obstet2008,30,6:1
14Gastrin-releasing peptide receptor as a molecular target for psychiatric and neurological disoiders显示文摘Roesler R Henriques JA Schwartsmann G 2006CNS Neurol Disord Drug Targets2006,5,:1
15Anti-cancer drugs discovery and development in BrazilPTargeted plant collectionas a rational strategy to acquire candidate anti-cancer compounds 显示文摘Mans DR Rocha AB Schwartsmann G 2000Oneologist2000,5,3:1
16Natural products in anticancer therapy显示文摘Adriana B da Rocha Rafael M Lopes Gilberto Schwartsmann 2001Cancer2001,1,:1
17Marine organisms as a source of new anticancer a gents显示文摘 DaRocha AB Berlinck RGS 2001Lancet Onc2001,2,4:1
18Marine-derived anticancer agents in clinical trials 显示文摘Schwartsmann G Da Rocha AB Mattei J 2003Expert Opin lnvestig Drugs2003,12,8:1
19Failure of anti-EGFR therapy in pl6-posi- tire head and neck cancer显示文摘Roesler R Schwartsmann G 2013Lancet Oncol2013,14,11:1
20Preliminary results from a phase I/II study of perillyl alcohol intranasal administration in adults with recurrent maligant gliomas显示文摘DA FONSECA C O SCHWARTSMANN G FISCHER J 2008Surgical Neurology2008,70,3:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费